glp 1 drugs uk GLP-1 use in the is growing fast but there's a side most conversations aren't really talking about... For many people, it's not the medication itself that becomes the challenge More people with type 1

Loss in body weight is an independent prognostic factor for mortality in chronic heart failure: Insights from the GISSI-HF and val-HeFT trials

If these approaches alone dont lead to the results you want, theres no shame in seeking additional supporteveryones path to weight loss is different

Abbasinejad emphasizes movement as medicine. You dont need to become a marathon runner, but incorporating regular physical activity is essential

A glucagon-like peptide-1 drug mimics hormones in the body that boost insulin release, reduce glucagon and slow stomach emptying

The multiple hit hypothesis is the most favored explanation for the pathophysiology of both pediatric and adult-onset MASLD

Roehnelt explains how insulin functions in the body, what happens when insulin resistance develops, and why chronically elevated insulin drives inflammation, weight gain, metabolic dysfunction, and disease progression